Inmed Pharmaceuticals INC. (INM) — DEF 14A Filings
All DEF 14A filings from Inmed Pharmaceuticals INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
InMed Seeks Shareholder Nod for Major Equity Issuance, Virtual AGM Set
— Nov 3, 2025 Risk: high
InMed Pharmaceuticals Inc. (INM) is holding its Annual General and Special Meeting virtually on December 17, 2025, to address several key items, including the e -
InMed Pharmaceuticals Files Proxy Statement
— May 16, 2025 Risk: medium
InMed Pharmaceuticals Inc. filed its definitive proxy statement on May 16, 2025, for its annual meeting of shareholders. The filing outlines the proposals to be -
InMed Pharmaceuticals Files 2024 Proxy Statement
— Oct 28, 2024 Risk: medium
InMed Pharmaceuticals Inc. filed its definitive proxy statement on October 28, 2024, for its annual meeting on December 18, 2024. The company, headquartered in
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX